Research Article

Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension

Table 1

Clinical characteristics of patients.

No PH (n = 61)Improved PH (n = 35)Persistent or new-onset PH (n = 28) value

Age (years)78 ± 781 ± 779 ± 90.149
Male sex, n (%)31 (50.0%)17 (27.4%)14 (22.6%)0.892
BMI (kg/m2)24.57 (22.57, 27.39)22.10 (21.37, 24.63)23.96 (20.17, 26.72)0.068
Medical history
 HT, n (%)41 (67.2%)23 (62.2%)17 (60.7%)0.796
 DM, n (%)19 (31.1%)11 (29.7%)6 (21.4%)0.630
 CHD, n (%)19 (31.1%)13 (35.1%)9 (32.1%)0.919
 AF, n (%)7 (11.5%)7 (18.9%)7 (25.0%)0.257
Clinical characteristics
 SBP (mmHg)138 ± 23133 ± 24135 ± 220.547
 DBP (mmHg)75 ± 1371 ± 1573 ± 110.279
 HR (bpm)76 ± 1683 ± 1879 ± 170.104
 FPG (mmol/L)5.33 (4.67, 8.02)5.59 (4.84, 7.36)5.38 (5.00, 7.00)0.916
 WBC (×109/L)6.77 ± 0.336.26 ± 0.327.49 ± 0.550.150
 RBC (×1012/L)4.12 ± 0.084.01 ± 0.103.97 ± 0.150.504
 HB (g/L)125.62 ± 2.22122.26 ± 3.13117.46 ± 4.820.196
 PLT (×109/L)191.45 ± 6.70166.71 ± 8.77199.43 ± 14.050.059
 RDW_SD (fL)43.40 (41.40, 45.85)45.60 (43.10, 50.90)47.35 (43.00, 52.40)0.001
 RDW_CV0.13 (0.12, 0.14)0.13 (0.13, 0.14)0.14 (0.13, 0.16)0.001
 MPV (fL)10.50 (9.90, 11.20)10.80 (9.90, 11.80)10.90 (10.23, 11.20)0.274
 PDW (fL)12.43 ± 2.3113.26 ± 2.6512.70 ± 2.110.262
 NEUT (×109/L)4.05 (3.21, 5.50)4.32 (3.58, 5.69)4.60 (3.79, 7.02)0.295
 LYM (×109/L)1.73 ± 0.911.25 ± 0.651.30 ± 0.750.008
 NLR2.74 (1.67, 4.29)3.48 (2.54, 5.68)5.78 (2.09, 8.89)0.024
 PLR65.21 (43.58, 111.22)46.56 (29.18, 63.39)37.99 (18.41, 96.35)0.017
 ALT (U/L)16.00 (11.00, 25.50)23.00 (11.00, 40.50)27.00 (17.00, 37.00)0.181
 AST (U/L)19.00 (16.00, 25.25)28.00 (19.00, 46.00)27.00 (19.00, 37.00)0.008
 T-BIL (umol/L)12.44 ± 1.0116.87 ± 2.5315.80 ± 1.410.028
 r-GT (U/L)21.00 (14.00, 34.75)33.00 (18.80, 63.50)31.50 (25.50, 40.00)0.107
 TP (g/L)65.75 ± 1.8564.71 ± 1.5869.37 ± 2.550.246
 ALB (g/L)39.10 (37.20, 41.20)39.00 (37.55, 40.40)40.10 (37.28, 42.13)0.370
 TC (mmol/l)4.71 ± 1.214.53 ± 1.214.70 ± 1.120.783
 TG (mmol/l)1.25 (0.88, 1.64)0.95 (0.77, 1.29)0.94 (0.76, 1.53)0.065
 HDL-C (mmol/l)1.15 ± 0.361.08 ± 0.271.15 ± 0.280.560
 LDL-C (mmol/l)2.58 ± 0.832.55 ± 0.892.60 ± 0.830.981
 UA (mmol/L)340 ± 109416 ± 204416 ± 1610.025
 Scr (μmol/l)72 (64, 86)73 (63, 129)79 (63, 117)0.436
 eGFR (ml/min/1.73 m2)84.56 ± 29.4577.45 ± 36.3271.01 ± 36.610.188
 BNP (ng/L)300 (131, 937)1923 (523, 3164)1015 (379, 2172)<0.001
 Hs-cTnI (μg/L)0.06 (0.19, 0.35)0.13 (0.06, 0.39)0.11 (0.02, 0.53)0.247
Baseline echocardiographic data
 RVD (mm)17 ± 218 ± 217 ± 20.078
 LAVI (ml/m2)31.45 ± 9.1540.26 ± 10.5639.74 ± 13.16<0.001
 LVMI (g/m2)129 (112, 153)149 (120, 180)144 (114, 163)0.350
 LVEF (%)58 (48, 58)48 (37, 55)55 (49, 58)#0.002
E/e′ ratio15 ± 620 ± 820 ± 70.004
 AV velocity (m/s)4.48 ± 0.844.75 ± 1.124.81 ± 0.820.191
 Peak AV pressure (mmHg)83.53 ± 28.0995.54 ± 40.4995.79 ± 30.580.130
 Average AV pressure (mmHg)50.33 ± 17.0058.66 ± 26.1858.04 ± 21.060.111
 PAD (mm)23 (21, 25)24 (22, 26)25 (23, 27)0.024
 RVSP (mm)55 ± 1451 ± 80.166

PH, pulmonary hypertension; BMI, body mass index; HT, hypertension; DM, diabetes mellitus; CHD, coronary heart disease; AF, atrial fibrillation; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR heart rate; FPG, fast plasma glucose; WBC, white blood cell count; RBC, red blood cell count; HB, hemoglobin; PLT, platelet; RDW_SD, the red cell distribution width_Standard Deviation; RDW_CV, the red cell distribution width_Coefficient of Variation; MPV, mean platelet volume; PDW, platelet distribution width; NEUT, neutrophil count; LYM, lymphocyte count; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-lymphocyte-ratio; ALT, alanine aminotransferase; AST, aspartate aminotransferase; T-BIL, serum total bilirubin; r-GT, r-glutamyltranspeptidase; TP, total protein; ALB, albumin; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; UA, uric acid; Scr, serum creatinine; eGFR, estimated glomerular filtration rate; BNP, B-type natriuretic peptide; hs-cTnI, high-sensitivity troponin C; RVD, right ventricular diastolic diameter; LAVI, left atrial volume index; LVMI, left ventricular mass index; LVEF, left ventricular ejection fraction; E/e′, early diastolic transmitral flow velocity/lateral mitral annular myocardial velocity; AV, aortic valve; PAD, pulmonary artery diameter; RVSP, right ventricular systolic pressure. , vs. Group I; #, vs. Group II. , vs. Group I. The bold values indicate statistical significances () among the three groups.